Literature DB >> 708022

Pharmacological evaluation of cefaclor in volunteers.

G R Hodges, C Liu, D R Hinthorn, J L Harms, D L Dworzack.   

Abstract

The plasma and urine concentrations of cefaclor were measured after oral administration of single and multiple doses to volunteers. Cefaclor was rapidly absorbed, rapidly excreted in the urine, well tolerated without toxicity, and failed to accumulate in the plasma with chronic dosing.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708022      PMCID: PMC352480          DOI: 10.1128/AAC.14.3.454

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

Authors:  J Santoro; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  Comparative pharmacology of cefaclor and cephalexin.

Authors:  O M Korzeniowski; W M Scheld; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  In vitro susceptibility studies with cefaclor and cephalexin.

Authors:  W M Scheld; O M Korzeniowski; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

4.  Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.

Authors:  N J Bill; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

5.  In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria.

Authors:  S Shadomy; G Wagner; M Carver
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

6.  In vitro studies with cefaclor, a new oral cephalosporin.

Authors:  C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

  6 in total
  15 in total

1.  The effect of four different types of food on the bioavailability of cefaclor.

Authors:  S Karim; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jul-Sep       Impact factor: 2.441

2.  Comparative effect of different types of food on the bioavailability of cefaclor extended release tablet.

Authors:  B A H Khan; T Ahmed; S Karim; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

3.  The effect of four different types of diet on the bioavailability of loracarbef.

Authors:  A T Bapujee; T Singh; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

4.  Phase I study of multiple-dose cefprozil and comparison with cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.

Authors:  N C James; K H Donn; J J Collins; I M Davis; T L Lloyd; R W Hart; J R Powell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Phase I study of single-dose BMY-28100, a new oral cephalosporin.

Authors:  R H Barbhaiya; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

8.  Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

9.  Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction.

Authors:  G Hall; A Heimdahl; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

10.  Penetration of cefaclor into bronchial mucosa.

Authors:  G E Marlin; A J Nicholls; G R Funnell; R Bradbury
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.